Picard Medical IncPMI
Price$4.32Intrinsic value$1.2372% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $6.3M+43.5% YoYTTM through 30 Jun 2026
Net Income -$28MTTM through 30 Jun 2026
Free Cash Flow -$16MTTM through 30 Jun 2026

Margins

Current
Gross Margin23.9%
EBITDA Margin-245.4%
Operating Margin-392.3%
Net Margin-444.3%

Balance Sheet Health

Debt / Equity-2.26x
Current Ratio1.02x
Net Debt$3.2M
Cash & Equivalents$38K

Quality Metrics

Altman Z-Score-17.87
Piotroski F-Score5 / 9
FCF Margin-254.7%

Multi-Year Trend

Revenue
'24'25
FY2025: $4.9M
Diluted EPS-$0.75TTM
'24'25
FY2025: $-0.75

Dividend

No dividend

Capital Allocation

R&D Spend$4.8M
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.